Drug Trial Radar · NCT02760407
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
Last checked: Nov 19, 2026Latest source record: Sep 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,648
Actual
Start
Jun 6, 2016
Primary completion
Aug 2, 2019
Study completion Nov 5, 2019
Sponsor
- Lead sponsor
- R-Pharm International, LLCIndustry
- Sponsor type
- Industry
- Collaborators
- Quintiles, Inc.; OCT Clinical Trials
- First posted
- May 3, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study was to determine how effective and safe the study drug Olokizumab was in patients with Rheumatoid Arthritis (RA) who had been already receiving but not fully responding to treatment with methotrexate (MTX). The primary objective of this study was to evaluate the efficacy of OKZ 64 mg administered subcutaneously (SC) once every 2 weeks (q2w) or once every 4 weeks (q4w) relative to placebo in subjects with moderately to severely active RA inadequately controlled by MTX therapy. The secondary objective was to evaluate the efficacy of OKZ relative to adalimumab in subjects with moderately to severely active RA inadequately controlled by MTX therapy.
Conditions
- Rheumatoid Arthritis
Interventions
Olokizumab 64mg q4wDrug
160 mg/mL sterile solution for SC injection in a 2 mL clear Type I glass vial
Olokizumab 64mg q2wDrug
160 mg/mL sterile solution for SC injection in a 2 mL clear Type I glass vial
Adalimumab 40mg q2wDrug
0.4 or 0.8 mL prefilled, single-dose syringe
Placebo q2wDrug
sodium chloride 0.9% solution supplied in either a 10 mL vial or ampoule, depending on market availability. Each placebo will be packed into a cardboard carton to contain 1 vial or ampoule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects Achieving American College of Rheumatology 20% (ACR20) ResponseTime frame: at Week 12
Locations
203 sites in 18 countries. Site status is shown where the registry gives one.
Arizona Arthritis & Rheumatology Associates, P.C.
Mesa, Arizona
Arizona Arthritis & Rheumatology Associates, P.C.
Phoenix, Arizona
Arizona Arthritis & Rheumatology Research, PLLC
Sun City, Arizona
Medvin Clinical Research
Covina, California
TriWest Research Associates
El Cajon, California
MD Med Corp.
Hemet, California
Valerius Medical Group
Los Alamitos, California
Rheumatology Center of San Diego
San Diego, California
East Bay Rheumatology Medical Group, Inc.
San Leandro, California
Pacific Arthritis Center Medical Grpoup
Santa Maria, California
Inland Rheumatology Clinical Trials
Upland, California
Center for Rheumatology Research
West Hills, California
Medvin Clinical Research
Whittier, California
Denver Arthritis Clinic
Denver, Colorado
New England Research Associates LLC
Bridgeport, Connecticut
Javed Rheumatology Associates
Newark, Delaware
RASF - Clinical Research Center
Boca Raton, Florida
Reliable Clinical Research, LLC
Hialeah, Florida
Pharmax Research Clinic, Inc.
Miami, Florida
Medical Research Center of Miami
Miami, Florida
Omega Research Consultants
Orlando, Florida
Arthritis Research
Palm Harbor, Florida
Family Clinical Trials, LLC.
Pembroke Pines, Florida
AdventHealth Medical Group, PA
Tampa, Florida
Lovelace Scientific Resources, Inc.
Venice, Florida
Arthritis Center of North Georgia
Gainesville, Georgia
Marietta Rheumatology Associates, PC
Marietta, Georgia
Institute of Arthritis Research
Idaho Falls, Idaho
Springfield Clinic, LLP
Springfield, Illinois
University of Kansas Hospital
Kansas City, Kansas
Graves Gilbert Clinic
Bowling Green, Kentucky
The Arthritis & Diabetes Clinic, Inc.
Monroe, Louisiana
Klein and Associates, M.D., P.A.
Hagerstown, Maryland
The Center for Rheumatology and Bone Research
Wheaton, Maryland
AA MRC LLC Ahmed Arif Medical Research Center
Grand Blanc, Michigan
North MS Medical Clinics, Inc.
Tupelo, Mississippi
Glacier View Research Instutute-Rheumatology
Kalispell, Montana
Physician Resrch Collaboration
Lincoln, Nebraska
Arthritis & Osteoporosis Associates, PA
Freehold, New Jersey
NYU Langone ambulatory care
Brooklyn, New York
Showing 40 of 203 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.